The gastric emptying effect is particularly relevant when considering the timing of GLP-1 initiation after surgery
ALLERGEN FREE ENERGY SUPPORT: Formulated with methylated vitamins to support nutrient absorption, our all-in-one vitamin powder promotes sustained energy thoughout the day
17:515-524 [PubMed: 38733378] 212

Back to Journals Diabetes, Metabolic Syndrome and Obesity Volume 10 Sitagliptin ameliorates oxidative stress in experimental diabetic nephropathy by diminishing the miR-200a/Keap-1/Nrf2 antioxidant pathway Authors Civantos E, Bosch E, Ramirez E, Zhenyukh O, Egido J, Lorenzo O, Mas S Received 17 January 2017 Accepted for publication 22 March 2017 Published 7 June 2017 Volume 2017:10 Pages 207222 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Professor Ming-Hui Zou Esther Civantos, 1,2 Enrique Bosch, 1 Elisa Ramirez, 1 Olha Zhenyukh, 1 Jess Egido, 1,2 Oscar Lorenzo, 1,2 Sebastin Mas 1,2 1 Renal, Vascular and Diabetes Research Laboratory, IIS-Fundacin Jimnez Daz, Autonoma University, 2 CIBERDEM (Biomedical Research Centre in Diabetes and Associated Metabolic Disorders), Madrid, Spain Background: Sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor used in type 2 diabetes therapy, has demonstrated protective effects in diabetic chronic kidney disease, in part due to its pleiotropic actions

Stols-Gonalves D, Hovingh GK, Nieuwdorp M, Holleboom AG
These are prescription medications with real side effects, most commonly nausea and other stomach issues, and theyre meant to be used under medical supervision